Chemoinformaics analysis of 2-ETHYL-2-METHYLTRIDECAN-1-OL
Molecular Weight | 242.447 | nRot | 12 |
Heavy Atom Molecular Weight | 208.175 | nRig | 21 |
Exact Molecular Weight | 242.261 | nRing | 0 |
Solubility: LogS | -6.881 | nHRing | 0 |
Solubility: LogP | 6.569 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 50.193 |
nHD | 1 | BPOL | 34.109 |
QED | 0.46 |
Synth | 4.712 |
Natural Product Likeliness | 2.996 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.98 |
Pgp-sub | 0.012 |
HIA | 0.006 |
CACO-2 | -4.766 |
MDCK | 0.00000751 |
BBB | 0.621 |
PPB | 0.999501 |
VDSS | 1.565 |
FU | 0.0131729 |
CYP1A2-inh | 0.032 |
CYP1A2-sub | 0.577 |
CYP2c19-inh | 0.089 |
CYP2c19-sub | 0.97 |
CYP2c9-inh | 0.119 |
CYP2c9-sub | 0.083 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.301 |
CYP3a4-inh | 0.266 |
CYP3a4-sub | 0.917 |
CL | 13.668 |
T12 | 0.026 |
hERG | 0.026 |
Ames | 0.036 |
ROA | 0.417 |
SkinSen | 0.072 |
Carcinogencity | 0.053 |
EI | 0.012 |
Respiratory | 0.903 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.674224 |